Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Report for Q1 2026

Apr 17, 2026 · Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Hpgc Renmintongtai Pharmaceutical Corporation Class A

Announcement on Confirming Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration PlanApr 11

All Hpgc Renmintongtai Pharmaceutical Corporation Class A news releases